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Background: In endemic regions of sub-Saharan Africa, malaria during pregnancy (MiP) is a major preventable
cause of maternal and infant morbidity and mortality. Current recommended MiP prevention and control includes
intermittent preventive treatment (IPTp), distribution of insecticide-treated bed nets (ITNs) and appropriate case
management. This article explores the social and cultural context to the uptake of these interventions at four sites
across Africa.
Methods: A comparative qualitative study was conducted at four sites in three countries: Ghana, Malawi and Kenya.
Individual and group interviews were conducted with pregnant women, their relatives, opinion leaders, other
community members and health providers. Observations, which focused on behaviours linked to MiP prevention
and treatment, were also undertaken at health facilities and in local communities.
Results: ITNs were generally recognized as important for malaria prevention. However, their availability and use
differed across the sites. In Malawi and Kenya, ITNs were sought-after items, but there were complaints about avail-
ability. In central Ghana, women saved ITNs until the birth of the child and they were used seasonally in northern
Ghana. In Kenya and central Ghana, pregnant women did not associate IPTp with malaria, whereas, in Malawi and
northern Ghana, IPTp was linked to malaria, but not always with prevention. Although IPTp adherence was common
at all sites, whether delivered with directly observed treatment or not, a few women did not comply with IPTp often
citing previous side effects. Although generally viewed as positive, experiences of malaria testing varied across the
four sites: treatment was sometimes administered in spite of a negative diagnosis in Ghana (observed) and Malawi
(reported). Despite generally following the advice of healthcare staff, particularly in Kenya, personal experience, and
the availability and accessibility of medication – including anti-malarials – influenced MiP treatment.
Conclusion: Although ITNs were valued as malaria prevention, health messages could address issues that reduce
their use during pregnancy in particular contexts. The impact of previous side effects on adherence to IPTp and
anti-malarial treatment regimens during pregnancy also requires attention. Overtreatment of MiP highlights the
need to monitor the implementation of MiP case management guidelines.
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In endemic regions of sub-Saharan Africa, malaria during
pregnancy (MiP) is a major preventable cause of maternal
and infant morbidity and mortality [1]. Malaria during
pregnancy compounds or provokes anaemia, which, when
severe, increases the risk of maternal death (estimated at
around 10,000 deaths annually [2]). Low birth weight
(linked to around 100,000 annual infant deaths in Africa
[2]), pre-term delivery, congenital infection and reproduct-
ive loss are also linked to MiP [3]. Nonetheless, in spite of
its associated high burden of morbidity and mortality,
MiP was, until recently, recognized as a neglected area of
research [4].
Current recommended MiP prevention and control
strategies in areas of stable moderate to high malaria trans-
mission include the administration of intermittent prevent-
ive treatment (IPTp) with sulphadoxine-pyrimethamine
(SP), distribution of insecticide-treated bed nets (ITNs)
and appropriate case management [5]. Despite the pro-
gress made in the last decade, the coverage of IPTp and
ITNs amongst pregnant African women remains inad-
equate [6]. For proper case management, the most appro-
priate treatment depends on the malaria species, severity
of infection, local patterns of drug resistance, drug avail-
ability and gestational age [7]. This, combined with incom-
plete MiP surveillance data across sub-Saharan Africa [5],
complicates estimates of appropriate case management.
Nevertheless, given the insufficient availability of diagnostic
tests and artemisinin-based combination therapy (ACT)
[5] (recommended as first-line treatment for MiP during
the second and third trimester), case management is likely
to be sub-optimal.
In response to the challenges of MiP prevention and
control, a research consortium of 47 partner institutions
in 32 countries, was established and is currently con-
ducting a wide range of scientific activities in Africa,
Asia, Australasia (Papua New Guinea) and South America
[8]. The MiP Consortium takes a multi-disciplinary ap-
proach to MiP, bringing together immunologists, epide-
miologists, public health experts and social scientists.
This paper draws on the results of an anthropological
programme of research that forms part of the consor-
tium’s Public Health Impact Group.
The overall goal of the anthropological research car-
ried out under the auspices of the MiP Consortium is to
contribute to the development and implementation of
appropriate MiP interventions by gaining an in-depth
understanding of the social and cultural context of MiP.
A review of previously conducted research identified
four broad topics that influence the uptake of MiP inter-
ventions [9]: concepts of malaria and risk in pregnancy;
attitudes towards malaria prevention and treatment; per-
ceptions of antenatal care (ANC) services; and structural
factors. These four themes have been widely explored bythe MiP Consortium’s Anthropology Team. This article
focuses on attitudes towards MiP prevention and man-
agement (testing and treatment); two separate articles
focus on attitudes towards concepts of malaria and risk
during pregnancy [10] and perceptions of ANC [11].
The analysis of the structural factors affecting MiP pre-
vention and control is integral to all three articles.
In recent years, the malaria research and policy commu-
nity has increasingly emphasized accurate diagnosis to en-
sure appropriate treatment of malaria. In the absence of
diagnostic tests, malaria is commonly over-diagnosed be-
cause of its non-specific symptoms: headache, fatigue, ab-
dominal pain, muscle and/or joint aches, fever, chills,
perspiration, vomiting and malaise [12]. Therefore, as a re-
sult of concerns about overuse of malaria drugs, the 2010
WHO Guidelines for the treatment of malaria recom-
mended diagnosis by microscopy or rapid diagnostic test
(RDT) for all persons suffering from suspected malaria
prior to treatment [12]. Moreover, there is overlap be-
tween malaria and women’s other health complaints dur-
ing pregnancy. Thus diagnostic confirmation of MiP is
particularly important for appropriate management [13]
and is a key issue for this article.
To provide insight into the social and cultural context
to the uptake of interventions for malaria prevention
and control, this article addresses the following research
questions: what are the attitudes and behaviours towards
MiP prevention and management amongst pregnant
women, healthcare staff and other community members
in four sites in Ghana (northern and central), Kenya
(Nyanza Province) and Malawi (southern region); how
does the social and cultural context influence these atti-
tudes and behaviours; and what are the implications of
the attitudes and behaviours for the design of effective
MiP interventions? To identify and examine relevant is-
sues that might otherwise be taken for granted, a com-
parative approach is taken and data are presented from
four sites.
Methods
The results presented in this article are drawn from a
comparative study conducted at four sites in three
countries. The study was undertaken by a team of re-
searchers whose members were based across the sites
and in Barcelona (Spain).
Settings
The study incorporated one country from each of the
three main regions of Sub-Saharan Africa: Ghana in West
Africa, Kenya in East Africa and Malawi in Southern
Africa. Two sites with important regional specificities
were selected in Ghana for several reasons: to collect
data in at least one site of each of the MiP Consortium’s
main treatment and prevention activities; to include areas
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examine intra as well as inter-country variation.
In central Ghana, fieldwork was conducted in two dis-
tricts of the Ashanti Region: Ejisu Juaben and Ahafo
Ano South. In both districts, agriculture is the main pro-
ductive activity and there is a significant proportion of
internal migrants, in addition to the majority ethnic
group, the Asante [14]. At this site, malaria transmission
is moderately high and occurs throughout the year with
peaks during the rains in May-October [15]. In each dis-
trict, data collection was conducted at the district hos-
pitals, two to three health centres and several smaller
clinics.
In northern Ghana, Upper East Region, the fieldwork
sites were located in Kassena-Nankana District. This
area is part of the Sahel and experiences only one annual
rainy season during which people grow millet, maize
and vegetables for subsistence. During the rest of the
year, part of the population migrates to other regions.
The Kassena and the Nankani, make up almost 90% of
the population of the district [16]. Here, malaria trans-
mission is perennial but there is a seasonal pattern with
a transmission peak that coincides with the major rains
(May to October) and the low rates of infection during
the dry season [17]. Data were collected at a district hos-
pital in Navrongo, (the capital), and outreach community-
based services, which are common throughout the area.
Fieldwork also took place in Chikwawa and Blantyre
Districts, in the southern region of Malawi. The main
ethnic groups in Blantyre District are Chewa and Yao,
whereas in Chikwawa they are Manganja and Sena. Most
of the women in the area cultivate crops for subsistence
and sale at the market. Both districts are in areas of high
perennial malaria transmission [18]. Fieldwork took place
at three hospitals, and six healthcare centres that provide
ANC services to the women in these areas.
Finally, in Kenya, fieldwork was carried out in Siaya
District (Nyanza Province) where the principal ethnic
group, the Luo, make up over 95% of the population.Table 1 Respondents
Data collection activities Respondent type Central Gha
Free listing and sorting Community members
Pregnant women
Health providers*




Case studies Pregnant women
Focus group discussions Community members
*Includes healthcare staff involved with the provision of ANC at health facilities andLivelihood activities include subsistence farming of maize,
sorghum, millet and cassava. As a result of the relatively
limited employment opportunities, migration to urban
centres is common, particularly to Kisumu, the nearest
city. Malaria transmission is high and perennial [19] with
the greatest disease burden borne by children and preg-
nant women. Data were collected at the district hospital
and smaller health facilities where ANC is delivered.
At each of the sites, various clinical and non-clinical
studies of MiP prevention and control interventions
have been undertaken. Some of these studies overlapped
with data collection for this research. Therefore, during
data collection and analysis, efforts were made to exclude
experiences of MiP prevention and control within clinical
or non-clinical research. Furthermore, throughout this
article, for reasons of brevity, the sites are referred to as
“Kenya”, “Malawi”, “central Ghana” and “northern Ghana”.
This shorthand should not however be interpreted as any
attempt at regional or national generalization.
Data collection
An anthropological approach was taken to data collection.
This entailed year-long (or longer) periods of fieldwork at
each site, a range of data collection activities, including
narrative and observational techniques (see Table 1 for a
full list of data collection activities), and a flexible, reflexive
and iterative process of tool design, data collection, and
analysis. The use of multiple data collection tools with
heterogeneous respondents ensured that findings could be
triangulated and their reliability tested. To reduce the pos-
sible influence of individual bias on the study findings, at
each site, several researchers collected data.
Fieldwork was carried out between April 2009 and August
2011, and lasted from one year in Malawi to more than
two years in central Ghana. Assisted by two Barcelona-
based researchers (AM and CP), fieldworkers spent ex-
tended periods of time in the settlements where data were
collected and recorded their experiences of participant ob-
servation in field diaries. In the first phase, at each site,na Northern Ghana Kenya Malawi Total
12 16 17 24 59
10 10 7 11 38
10 11 6 5 32
84 64 69 68 285
33 34 17 21 105
26 29 20 16 91
12 12 10 12 46
19 18 12 18 67
10 16 9 16 51
TBAs working in the communities.
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explored the main problems that pregnant women experi-
ence. Later, interviews and group discussions were con-
ducted, several women (case studies) were followed and
interviewed several times over the course of their preg-
nancies, and observations were carried out in the commu-
nities and at local health facilities. The language used to
interact with informants depended on their preferences
(English and different local languages). In-depth inter-
views and group discussions were recorded, transcribed
and translated into English.
In-depth interviews tended to start with broad re-
search questions related to pregnancy and ended with
questions about malaria in pregnancy and experiences
with malaria prevention and control. In contrast, group
discussions often started with general questions about
malaria, focusing later on groups particularly vulnerable
to malaria and finalizing with malaria prevention and
control. Other themes, related to MiP, such as miscar-
riage, stillbirths, pre-term deliveries, birth weight and
anaemia – and their causes – were also explored during
fieldwork. Data collection and analysis were carried out in
parallel allowing the incorporation of emerging themes in
the design of the tools, and questions’ redefinition and
attuning.
Members of the Barcelona-based research team made
quarterly visits to the study sites. During these visits, a
process of debriefing and reflection took place with
fieldworkers. The Barcelona-based researchers were also
able to participate in data collection, and provide ongoing
training.
Respondents
Five main categories of respondents were interviewed
(Table 1): pregnant women, their relatives, community
members, opinion leaders and healthcare providers. Pur-
posive sampling was used to ensure the interaction with
a wide range of experiences. Married and unmarried
pregnant women of a range of ages, parities and gesta-
tional ages from across the different settlements (within
the field sites) were interviewed. Relatives included
mainly mothers, mothers-in-law and husbands of the
pregnant women. The sample of opinion leaders was
made up of a variety of religious leaders, traditional and
political authorities, and relevant women in the local
communities. Finally, ANC staff, pharmacists and drug
sellers, traditional birth attendants (TBAs), and other
healers (who attended to pregnant women or dealt with
malaria) were interviewed at each site. Respondents were
identified in ANC clinics and via contacts in the local
communities, which developed as fieldwork went on.
The final number of participants was a result of the di-
rected sampling and the point of saturation, whereby no
further novel insights were identified from interviews.Data analysis
At each site, a first phase of data analysis ran in parallel
to data collection. Using Atlas.ti 6, flexible codebooks
were developed and revised using a combination of
established categories based on the original research
questions and themes that emerged from the data. Par-
ticular attention was paid when analyzing the interviews
with case studies to identify changes in a woman’s re-
sponses over the course of her pregnancy, for example,
with regard to ITN use. The preliminary results obtained
from this site-specific analysis were compared and dis-
cussed amongst the members of the team in periodic
meetings throughout data collection. In a second phase,
data associated to the codes relevant to malaria in preg-
nancy perceptions, were extracted, collated and discussed
between authors one and two, looking at the similarities,
differences and variations between and within the different
sites.
Ethics statement
Overall ethics clearance was obtained from the Clinical
Research Ethics Committee, Hospital Clinic-University
of Barcelona. Separate local ethics clearance was ob-
tained at each site: in Ghana, clearance was obtained
from the Institutional Review Board of the Navrongo
Health Research Centre, Navrongo and the Committee
on Human Research Ethics, Kwame Nkrumah University
of Science & Technology, Kumasi; in Kenya, clearance
was obtained from the Institution Review Board of Cen-
ters for Disease Control and Prevention, Atlanta and
from the National Ethics Review Committee, Kenya
Medical Research Institute, Nairobi; and in Malawi,
clearance was obtained from the College of Medicine
Research and Ethics Committee. As approved by all
ethics review committees and institutional review
boards, informed consent was obtained orally from study
participants. Oral rather than written informed consent
was obtained because the study procedures posed min-
imal risk to study participants and to avoid the possible
negative influence of a written consent on rapport be-
tween researchers and respondents. With the agreement
of participants, verbal consent was voice recorded prior




Sleeping under an ITN was generally recognized as the
main way to prevent malaria (or the local illnesses that
overlapped with biomedically defined malaria at each
site, which, although not addressed specifically here, are
discussed in a separate article [10]). The availability and
use of ITNs however differed across the four sites (see
Table 2).
Table 2 Insecticide-treated bed nets (ITNs) for pregnant women: policies, availability and preferences
Site Policy Shortages Availability and use
Kenya Free delivery at health facilities No Pregnant women report sleeping under ITNs
Pregnant women claim ITNs are not provided
Observations in houses confirm presence of ITNs
Malawi Free delivery at health facilities Observed Pregnant women report sleeping under ITNs
Ghana (northern) Sold in health facilities at subsidized prices Observed Cases of seasonal use of ITNs
Pregnant women complain about costs of ITNs
Ghana (central) Sold in health facilities at subsidized prices No Pregnant women report saving for use after delivery
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In Ghana, ITNs were sold in the health centres at ANC
at a subsidized price but purchases were rarely observed.
Moreover, in Northern Ghana, shortages of nets were
encountered. No national mass ITNs distribution cam-
paigns were observed during fieldwork, however, a non-
governmental organization distributed free ITNs to the
local population and a limited number of our informants
in northern Ghana received an ITN.
In Malawi, insecticide-treated bed nets were distributed
free of charge to pregnant women at health facilities on
two occasions: at first ANC visit, and once after delivery.
Observed shortages however supported pregnant women’s
claims of not always receiving an ITN. Bed nets were
sought-after items in Kenya and, although healthcare staff
reported providing ITNs to all women who attend ANC
(and observations suggested that they were plentiful at
health facilities), there were complaints from pregnant
women of ITNs not being handed out as part of ANC.
ITN ownership and use
At all sites, pregnant women reported a demand for
ITNs. Although they complained about their price,
Ghanaian women reported sleeping under ITNs. How-
ever, in central Ghana there were women who, in spite
of owning an ITN, only used it after giving birth; these
women considered their newborns to be at greater risk
of malaria and also valued new possessions to mark the
birth of a child. In northern Ghana, women used ITNs
in the wet season because mosquitoes were present and
they slept indoors. However, in the dry season, due to
the heat, outside sleeping was the norm and ITNs were
therefore not used. In Kenya and Malawi, although
household sleeping arrangements and the lack of space
in dwellings prevented some pregnant women from
sleeping under ITNs (particularly if children were given
priority), respondents generally reported that they used
their ITNs, sometimes sleeping alongside their youngest
children. Moreover, in Kenya, ITNs were often directly
observed hanging in respondents’ dwellings. The value
that Kenyan respondents placed on ITNs was also linked
to their observed multiple uses: for example, as gardennetting, fishing nets, latrine doors, crop protectors and
decorative wall hangings.
During fieldwork, there were also very scattered re-
ports of opinions that might deter women from sleeping
under ITNs. In Kenya, there were infrequent references
to feeling hot and suffocated when under the ITN, and
similar comments about heat discouraging people from
sleeping under ITNs in Malawi and Ghana. In Malawi
and Ghana, although rare, criticisms were made of the
insecticides used to treat the ITNs.
IPTp
Availability of IPTp
Policies regarding IPTp delivery varied across the sites:
in Malawi, women were to be administered two doses of
IPTp, whereas, in Ghana, policy stipulated a three-dose
regimen. In Kenya, at least two doses were to be delivered
at monthly intervals after quickening. At all sites, short-
ages of SP for IPTp were not encountered and healthcare
staff described them as exceptional occurrences.
Knowledge of IPTp
In central Ghana and Kenya, pregnant women did not
usually associate IPTp with malaria, whereas, in Malawi
and northern Ghana, IPTp was associated with malaria,
but not always with prevention. In central Ghana, only a
minority of pregnant women recalled being given pills to
prevent malaria; when probed about the tablets that they
received during ANC visits, the majority did not know
what they were for or interpreted them as intended for
general pregnancy care. Moreover, younger mothers
were less aware of the drugs provided.
Interviewer (I): Why do you think they gave you those
three medicines?
Respondent (R): I didn’t ask them. When they gave
them to me, I took them over there. So
I didn’t ask them why they gave them
to me but I know they gave them to me
because of the pregnancy.
(Central Ghana, in-depth interview with a pregnant
woman, 24 years old, one child)
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IPTp as malaria treatment or prevention. Although a
small minority of respondents recalled taking “Fansidar”
(the brand name for SP) during ANC visits to prevent
malaria, those who did not, when probed about the
white tablets supplied during ANC, reported that they
were de-worming tablets, tablets to cure their (mild)
malaria/fever, multi-vitamins or they simply did not recall
receiving them (in spite of healthcare staff reporting that
all women receive IPTp). Although a lack of communica-
tion between healthcare staff and pregnant women during
ANC was observed at this site (and at other sites), the
Kenyan women who said that they asked health care staff
specifically about the white tablets reported that they re-
ceived information.
In northern Ghana, there was greater awareness of
malaria drugs being administered during ANC: around
half of the interviewed pregnant women referred to the
malaria drugs, but most were unaware that they were
intended as prevention. Pregnant women’s knowledge of
IPTp was also high in Malawi: most respondents were
familiar with “Fansidar” as an anti-malarial drug given to
pregnant women and, when administered during ANC,
it was considered to provide protection from malaria for
the mother and the unborn child and/or treatment for
the pregnant woman’s malaria.
I: What about the Fansidar they gave you, what was it
for?
R: It protects against malaria but also deals with
general body pains.
(Malawi, in-depth interview with a pregnant woman,
25 years old, two children)Attitudes towards IPTp
The lack of awareness of IPTp in Kenya and central
Ghana complicated attempts at assessing attitudes to
IPTp or SP. However, regardless of whether pregnant
women were familiar with IPTp, complaints of side
effects linked to the medication received during ANC
visits (largely nausea and dizziness) were uncommon
at these sites. In Malawi and Northern Ghana, direct
complaints about side effects of IPTp, especially
vomiting, were more common. This was in spite of
women’s greater efforts to reduce the possibility of
side effects at these sites: here, women were often ad-
vised by healthcare staff to eat a meal before receiving
IPTp to prevent nausea or vomiting. These complaints
did not however necessarily lead to non-compliance
because IPTp was generally accepted (albeit some-
times begrudgingly) as part of the package of ANC
interventions, which was collectively viewed in a
positive light.I: Do you think that those medicines have disturbed
some pregnant women?
R: Yes, some women swallow and go out and vomit it
away but I have never swallowed it and vomited it out.
(Northern Ghana, in-depth interview with a pregnant
woman, 22 years old, one child)
IPTp-related behaviours
Observations highlighted how IPTp was not universally
administered according to the directly observed treat-
ment (DOT) protocol. This was often a result of
drinking-water being only available outside of the con-
sultation room: freely available from drinking fountains
in communal spaces or purchased from vendors on or
close to the health facility premises. However, at one
health facility in central Ghana, DOT was contingent on
other factors: prior to administering IPTp, healthcare
staff first enquired whether pregnant women had eaten.
If they had eaten prior to attending the health facility,
the SP was administered during the consultation under
DOT. However, if they had not eaten, the women were
instructed to take the SP away with them and to take it
after eating. These staff, therefore, prioritized the Ghanaian
policy guideline that stipulates women should have eaten
prior to receiving SP (which is contradicted by more re-
cent WHO guidelines [20]) over that which specifies DOT
for IPTp [21].
Instances of IPTp non-adherence were however en-
countered. In Kenya, for example, DOT was not always
followed because the drinking water fountain was lo-
cated in the waiting area and a woman was observed
slipping her tablets into her handbag on leaving the con-
sultation room). When asked about this, she explained
her non-adherence in terms of previous experiences of
vomiting after taking the same tablets. She was also un-
aware of the purpose of the medication. At the other
sites, there were also indirect reports (and one direct) of
non-adherence, and the following quotation hints at
non-adherence occurring even in cases of DOT.
I: Were you given some drugs to take instantly at the
initial visit?
R: Yes
I: What was the colour?
R: White
[…]
I: Were you told what it was meant for?
R: No
[…]
I: Did you have any problems when taking them?
R: I always vomited
[…]
I: Did you tell [the healthcare staff] that the medicine
was making you vomit?
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I. So did you take them and vomit again?
R: I didn’t take them again even though I was given
them.
I: But you are always asked to take them straight away?
R: I was given the drugs and water to take but I kept
[the tablets] in my purse.
I & R: [Laughter].
(Northern Ghana, in-depth interview with a pregnant
women between 20 and 25 years old, one child)
Generally though, according to healthcare staff and
pregnant women, even without DOT and even though
they may have been unaware about the name or purpose
of the medication, women took the SP when it was given
to them. This was even the case in both sites in Ghana,
where women had to buy water to swallow the tablets
from vendors in health facilities for a small fee (US
$0.05) that women viewed as an insignificant part of the
total cost of ANC (including transport costs etc.). In-
deed, during ANC visits, women followed instructions
from healthcare staff that provided the interventions
(see [11] for further details regarding ANC attendance).
Case management
Malaria diagnostic tests
Although generally positive, attitudes towards and
awareness of malaria testing varied across the sites. Preg-
nant women, and the community in general in central
Ghana, accepted healthcare staff as providing accurate
diagnoses of their health complaints, whether blood ana-
lyses were carried out or not. Women could however
not always recall the purpose of the tests – for malaria
or otherwise – during clinic visits.
I: How would you know a pregnant woman has
malaria?
R: It is only when she goes to the hospital would they be
able to tell whether she has malaria or not because
pregnant women are often weak. So you might even
think she is sick when she is not.
(Central Ghana, in-depth interview with the husband
of a pregnant woman, 35 years old)
In northern Ghana, pregnant women identified contra-
dictions between the messages provided in health facil-
ities and their own experiences of malaria: some women
complained of being frequently told that malaria was the
reason they were feeling unwell, whereas, on other occa-
sions, they thought that they had malaria but were not
given treatment. As the quotation below suggests, ambi-
guity was often linked to the breadth of the local illness
concept that approximated to biomedically defined mal-
aria (as is discussed in more detail elsewhere [10]).I: Did you not have malaria at a point in time?
R: Ok. There was a time when I went and told [the
healthcare staff] that I had malaria and they told me
that we should not always say that we have malaria,
but we should just say that we are sick, because we
cannot tell whether it is malaria or not. But I know
that I had malaria because I was vomiting.
I: Did they give you any malaria drugs?
R: Yes they gave me some. They made me go and do
some test before they gave me that medicine.
(Northern Ghana, an in-depth interview with a preg-
nant woman, 29 years old, one child)
At both sites in Ghana, health professionals described
the importance of diagnostic tests for accurate malaria
diagnosis. In these settings, however, health professionals
also explained that infants and pregnant women were
exceptions to the new policy on malaria case manage-
ment that stipulated a positive malaria test prior to ad-
ministering anti-malarials. Hence, pregnant women were
observed receiving anti-malarials without being tested
(even if a test was available) or despite a negative malaria
test result.
In Malawi, pregnant women viewed malaria diagnostic
tests as ambiguous. Although not always available, when
they were available, positive results were often trusted
and seen as confirmation of a diagnosis. In cases of a
negative result, the test was sometimes viewed as miss-
ing the infection. The subsequent lack of treatment also
disappointed women who had assumed that they were
suffering from malaria and expected to be treated. How-
ever, the following quotation from a focus group is one
example of the reports of treatment in spite of a negative
test result.
I: Can one have malungo (malaria) without knowing?
All: Quite.
[…]
R5: We get tested and then you know that you have
malungo even when you go [to the clinic] for
another disease and not malungo.
I: Is it possible to feel that you have malungo and at the
hospital they do not find it?
R1: Yes, it’s possible.
All: Yes.
I: So what happens when you have all the symptoms
and they do not find the malungo?
R5: They give AL (artemether-lumefantrine).
All: Yes.
(Malawi, a group discussion with local women)
In contrast, interviewed Malawian healthcare staff only
referred to treating after a positive result. Moreover, mal-
aria-like symptoms were said to be common amongst
Pell et al. Malaria Journal 2013, 12:427 Page 8 of 13
http://www.malariajournal.com/content/12/1/427pregnant women, but the rapid diagnostic test confirmed a
minority of these cases as malaria (one health worker re-
ferred to one in ten).
Kenyan respondents generally valued diagnostic tests
for malaria (and other diseases): they viewed them as ac-
curate and associated them with more effective treat-
ment. Indeed, one pregnant woman’s husband stressed
the need to travel the extra distance to the district hos-
pital to ensure access to diagnostic tests. Nonetheless,
respondents described having “malaria”, particularly mild
“malaria”, without having obtained a diagnosis (either
from a health worker based on clinical presentation or
the result of a blood test). This was linked to the broad
illness category of “malaria” that respondents described,
which did not necessarily match the biomedical definition
[10].
For the most part, malaria tests were only available
free of charge through the laboratories of medical re-
search institutes that were carrying out clinical studies
within the grounds of health facilities. In smaller health
centres, a malaria test was only available with the assist-
ance of staff from the medical research institutes, who
tested non-study patients when requested by healthcare
staff or when severe malaria was suspected. At the dis-
trict hospital, although malaria tests were sometimes
available in the Ministry of Health laboratory, charges
were commonly levied for these tests. There were there-
fore reports of healthcare staff administering anti-malarials
without a test.
Sometimes you may go to these [drug] shops and tell
them your problems for example, I have a headache
but they will not do a lab test so they will just give you
medicine thinking that it is malaria but it is not. Now
it is good to go to the hospital and get tested so that
you may know the problems that you are suffering
from
(Kenya, in-depth interview with a pregnant woman,
20 years old, two children)
Indeed, Kenyan healthcare staff viewed malaria –
symptomatic and asymptomatic – as common amongst
pregnant women. In light of this, a diagnostic test was
viewed as essential to confirm the diagnosis.
R: At least, out of all the admissions, you will find that
eight out of ten will have malaria. Almost all. And
half of them never feel ill. So when you take the
temperature that is when you realise but they don’t
complain. You see the [blood] slide.
I: So you are saying that eight out of ten have malaria
and most of them are not complaining.
R: Yeah most of them don’t complain, they just see it as
part of the discomfort of pregnancy but when nowyou are doing your research, and doing the blood
tests, they will say “ah, I don’t even have malaria”,
and you say let’s check. And you check and you will
see and have to treat, so that’s malaria.
(Kenya, in-depth interview with a healthcare provider)
Treatment
Type of anti-malarials
Across the four sites, all respondent types viewed bio-
medicine as the primary treatment option for malaria,
particularly severe malaria. Although some herbal rem-
edies were described, respondents reported their use to
be infrequent. In Malawi, references to non-biomedical
treatments for malaria were very scarce. In Kenya, pov-
erty was said to be a reason for pregnant women using
herbal remedies as a last resort for malaria. In central
Ghana, herbal malaria remedies were used, particularly
in rural areas by uninsured adults (to avoid the costs of
both transport and medical care) and on other occasions
for cases of mild malaria in addition to biomedical treat-
ments. At this site, the use of non-biomedical remedies
during pregnancy was common to ensure a safe delivery
and a healthy baby. However, no remedy specifically for
MiP was reported. In northern Ghana, adults and chil-
dren were regularly given herbal malaria treatments, but
pregnant women did not use them because of their bit-
ter taste, which was viewed as a cause of miscarriage.
I: Is there herbal medicine for paa (malaria)?
R: Yes it is there, but in this community they hardly give
herbs to pregnant women, because they are afraid,
they don’t know what is inside the stomach.
I: If you are not pregnant and you have paa, can you
use the local medicine?
R: Yes, you can use the “soli”, a long tree, and boiled
neem leaves. You use it to cover yourself, drink and
bathe.
(Northern Ghana, In-depth interview with a pregnant
woman, more than 35 years old, 4 children)
Availability of and access to anti-malarials
Anti-malarials, including SP, were available in drugstores
at both sites in Ghana. However, during fieldwork there
were no reports or observations of pregnant women
buying them; in theory, health care is free to pregnant
women (though they sometimes are faced with charges
[11]) and they therefore preferred to seek care at health
facilities. In Malawi, ACT was not easily available, except
in health facilities. Moreover, although at the beginning
of fieldwork, SP was available in grocery shops, it was
later prohibited and therefore increasingly unavailable as
stocks ran out. In both countries, women acknowledged
buying and taking painkillers, mainly paracetamol, with-
out prescription for mild symptoms of pregnancy and/or
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other respondents maintained that pregnant women
should to go to clinic to be prescribed drugs for (espe-
cially severe) malaria. However, women admitted having
bought drugs from local pharmacies without a prescrip-
tion or taking other medication that was not prescribed
for them (due to the “mildness” of the malaria, the high
price of the drugs recommended by healthcare staff, or a
reluctance to visit a health facilities, because of cost or
other reasons).
Knowledge and understandings of anti-malarials
In Ghana, pregnant women did not recall the names of
anti-malarials, but some could describe the colours of
the tablets, the doses and/or the packaging. In Malawi,
the names of anti-malarials were used even if respon-
dents identified them incorrectly. Malawian respondents
also viewed the effectiveness of a particular anti-malarial
as dependent on the individual: certain tablets were said
to suit some individuals better than others. And there was
a reasonable consensus amongst respondents regarding
which “malaria medicines” (even if not anti-malarials)
were appropriate for pregnant women: “Fansidar” (SP)
was mainly considered the anti-malarial for pregnant
women and a small proportion of pregnant women
stated that artemether-lumefantrine (AL), quinine, bac-
trim, penicillin and ibuprofen were too strong to be
used during pregnancy and that they can harm the un-
born child. Other women accepted AL as treatment for
pregnant women, provided that it “suits” the individual.
There were Kenyan respondents who recounted a list of
drugs to treat “malaria” and others who only mentioned
one or two. Their lists included painkillers or cold remed-
ies, often intended for mild illness episodes that were
labelled using the local illness that overlapped with biome-
dically defined malaria [10]. Indeed, across all the sites,
women reported using paracetamol (often termed “pana-
dol” or “para”) and aspirin for mild symptoms of pregnancy
and/or malaria. There were even reports of Ibuprofen use
during pregnancy. Kenyan women also mentioned Coar-
tem (AL) and quinine, which tended to be associated with
severe malaria. Respondents had varied opinions about tak-
ing “malaria drugs” during pregnancy: there were reports
of a need to consult healthcare staff, yet there were also
cases of pregnant women self-medicating with anti-
malarials. One woman was unsure about taking bitter
drugs during pregnancy and another was wary about tak-
ing “many drugs”.
Although women generally reported following the advice
of healthcare staff, in Kenya, the availability and accessibil-
ity of medication – including anti-malarials – could influ-
ence where women received treatment. For example, one
Kenyan woman attended a health facility for an acute ill-
ness and sought assistance where ANC is normallyprovided. However, ANC was not offered at that time, and
the healthcare staff who examined her instructed her to
pay for the anti-malarials. Unable to pay, she visited a drug
store where she bought drugs more cheaply. Such exam-
ples were however not observed nor reported in Malawi
or Ghana. Furthermore, in general, although compliance
with anti-malarial treatment regimens was not observed
directly, Kenyan women’s reports of anti-malarial use var-
ied: there were at least two reports of women using ACT
that they already had at home, for example, that had been
previously prescribed to a young child. Some women how-
ever emphasized the need to follow the instructions from
healthcare staff because of the dangers of taking medica-
tion during pregnancy.
In Ghana, the side effects of anti-malarials and the ad-
vice of health staff influenced whether pregnant women
completed the prescribed treatment course. In total,
four women were identified who did not complete their
prescribed treatment courses. For one of these women,
a health worker’s advice about sweetening medication
caused confusion: the woman associated the sweet taste
with malaria and was therefore deterred from complet-
ing the treatment course. In both Ghana and Malawi,
health talks and the advice given individually to pregnant
women at ANC included warnings about self-medication
and healthcare staff expressed concerns about the use of
non-prescribed drugs and traditional remedies. However,
in Ghana, health messages did not focus on adherence to
prescribed anti-malarial regimens.
Discussion
Across all the sites, respondents recognized that sleeping
under an ITN was a way of preventing malaria. Even
though respondents at all sites offered additional expla-
nations (such as poor hygiene) for a bout of malaria (or
the local illness that overlapped with biomedically de-
fined malaria (see [10] for further details), mosquitoes
were reported to be the main cause. The connections
that respondents made between ITNs use and malaria
prevention were therefore unsurprising. Malaria was also
viewed as a common disease for pregnant women, and
considered to be a cause (along with other contributing
factors) of miscarriage [10].
In addition, negative attitudes towards ITNs were rare
and there were no specific objections to their use during
pregnancy. This finding, in varied social and cultural
contexts with different mechanisms of ITN distribution,
contrasts with several previous studies that have high-
lighted health concerns linked to ITN use during preg-
nancy, particularly with regard to the impact of the
insecticide treatments on the unborn child [22-25].
These studies were carried out prior to the distribution
of long-lasting ITNs and it was often the insecticide, and
process of re-treatment, that provoked such concerns.
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negative attitudes towards ITNs including complaints
about distribution campaigns targeting pregnant women
and infants [26]. Such comments were attributed to a lack
of information linking increased malaria vulnerability with
ITN distribution [26]. By contrast, respondents in this
study often highlighted pregnant women’s increased risk
malaria [10] and no such negative comments about the
targeting of pregnant women were encountered.
The broader meanings associated with ITNs had vary-
ing implications for their use. In central Ghana, women
viewed ITNs as a consumer good and therefore left them
unused during pregnancy, hanging them up for the first
time to mark the birth of the child. Kenyan respondents
also valued ITNs as a household item with multiple uses,
such as protecting crops from birds. However, in this
context, the multiple uses of ITNs did not necessarily
prevent pregnant women from sleeping under them.
These findings are a reminder of how health technolo-
gies (in this case, intended by its designers for malaria
prevention) can take on quite different meanings and us-
ages. This is particularly the case in resource-poor con-
texts where material goods are scarce and this scarcity
can foster innovation.
More practical issues also had implications for ITN
use during pregnancy. In Kenya, occasionally, sleeping
arrangements together with the prioritization of children
sleeping under ITNs prevented pregnant women from
using the ITN that they received at ANC. In northern
Ghana, ITN use was seasonal, depending on the pres-
ence of mosquitoes and temperatures low enough to
sleep indoors. In Malawi, shortages of ITNs at health fa-
cilities limited the number of women who received free
ITNs and their use. However, when available, Malawian
women reported sleeping under ITNs.
As previous research has also highlighted [9,15,27],
knowledge of IPTp varies across different contexts. In
central Ghana and Kenya, pregnant women did not usu-
ally associate IPTp with malaria, whereas, in Malawi (as
has also been identified in previous research [28]) and
northern Ghana, it was more often linked to malaria,
but not always prevention. Reports of side effects linked
specifically to IPTp were therefore more prominent at
these sites and, in northern Ghana, vomiting was par-
ticularly associated with IPTp, and, therefore, seen as
one negative aspect of ANC. However, vomiting did not
lead directly to future non-compliance with IPTp or dis-
courage ANC attendance: often, regardless of side effects
and without supervision women took their malaria pre-
vention, “Fansidar” or “white tablets” because it was a
component of the ANC package, and in an effort to fol-
low the instructions of healthcare staff – see [11] for
more detail of ANC at the same sites. Similar confidence
in healthcare staff ’s instructions about IPTp has alsobeen identified in The Gambia [27] and Uganda [29].
Even so, the women who did not adhere to IPTp – and
there were suggestions that this occurred even if adminis-
tered under DOT – did so largely because of previous nega-
tive experiences. The instances of IPTp non-compliance
underscore a need for further in-depth (observational) re-
search on compliance in real-world settings to ensure that
uptake of IPTp is not overestimated.
Optimal treatment of MiP was hindered by a lack of
available malaria diagnostic tests and by negative test re-
sults being ignored. Pregnant women, along with other
community members, generally viewed healthcare staff
as the authoritative source of malaria diagnosis, particu-
larly severe malaria. Moreover, malaria tests were gener-
ally valued as a way of confirming the diagnosis. However,
even if available, the tests did not entirely dispel uncertainty
around the presence or absence of MiP. The non-specific
nature of its symptoms has prompted recent policy rec-
ommendations to test for malaria prior to administering
treatment [12]. Pregnancy however further complicates
the clinical diagnosis of malaria because there is overlap
between the symptoms of non-severe malaria and what
women often consider to be normal pregnancy experi-
ences [10] or related illness [13]. Although a positive test
result resolved any uncertainty for healthcare staff and
pregnant clients, a negative result was not so conclusive:
in Ghana and Malawi, observations and women’s reports
suggested that there instances of treatment in spite of a
negative result.
Ghanaian healthcare staff asserted that pregnant women
were exceptions to the policy of testing prior to treatment
and provided treatment based on symptoms even when a
malaria test result was negative. This is however a misin-
terpretation of the relevant policy document, which states
that, in the absence of laboratory diagnosis, pregnant
women with clinical symptoms of malaria should not be
denied anti-malarials because the risk of not treating far
outweighs the risks associated with overtreatment [21]. A
lack of confidence in malaria tests and reliance on symptoms
is however well-documented in other African contexts
[30,31]: for example, in northern Tanzania, overtreatment
of malaria in general was linked to a range of factors, in-
cluding healthcare staff members’ assumptions about mal-
aria being the most important disease and patients’
expectations [30]. Overtreatment of MiP in Ghana was
linked to a (mis)interpretation of national policy, yet the
findings offer little insight into how this came about. How-
ever, the emphasis placed on MiP and its deleterious im-
pact on the health of mother and child could have
contributed to the better-safe-than-sorry approach. The
reports of treatment in Malawi were however, more indir-
ect. Healthcare staff only referred to treatment after a
positive result, even if such tests were not readily available.
Pregnant women who suspected malaria but received a
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receive anti-malarials, but the data offer no insight into
whether this led healthcare staff to provide treatment.
With regard to malaria treatment, pregnant women
generally reported following the advice of healthcare
staff. However, although scattered, there were instances
of women ignoring such instructions or self-treating for
malaria without seeking diagnosis at a health facility. In
Ghana, where there were four cases of women who did
not complete their treatment course, side effects played
a role, as did confusion about the advice from healthcare
staff, particularly if it contradicted ideas about malaria
causation. In spite of such cases, health messages tended
to focus on the use of non-prescribed and non-biomedical
treatment during pregnancy and little emphasis was
placed on adherence to prescribed anti-malarial regimens.
The instances encountered in Kenya of women self-
treating with drugs from other sources stood out from the
other sites. Yet, although similar findings have been made
at another Kenyan site [32], it is unclear to what extent
they were indicative of a more systematic trend of self-
medication. At all the sites, women made use of paraceta-
mol and other cold remedies to combat the mild symptoms
associated with pregnancy and/or malaria. Such vague ideas
of “malaria” medication (presumably linked to the breadth
of the local illness that overlaps with malaria [10]), can con-
tribute to inappropriate use of anti-malarials and other
“malaria drugs” through self-treatment or non-adherence
to prescribed treatment regimens.
A preference for anti-malarials that “suit” an individual
was more prominent in Malawi than at the other sites.
Such ideas about compatibility were perhaps the most
extreme examples regarding the role that personal ex-
perience plays in attitudes and behaviours towards MiP
interventions. Because pregnancy is generally considered
to be a particularly vulnerable bodily state and one in
which women experience a range of health complaints
[10], it is unsurprising that women display a preference
for health interventions that are viewed as not contribut-
ing further to the negative symptoms of pregnancy. In-
deed, these experiences can – albeit rarely – override
women’s typical adherence to the instructions that health-
care staff provide.
Strengths and limitations
The strengths of this study are intertwined with the an-
thropological approach: fieldwork over a one to two year
period enabled observations to be carried out to triangu-
late the data that respondents shared with the research
team and enabled women to be interviewed multiple
times over the course of their pregnancy to develop rap-
port, cross-check previous responses and to monitor
their experiences of care over the course of a pregnancy
with a follow-up post-delivery. However, the findings,with regard to malaria interventions, are limited by several
factors. Regarding ITN use, reported use could not be
confirmed with observational data at all the sites: as a re-
sult of the organization of dwellings and the restrictions
on researchers’ access to sleeping spaces, only in Kenya
was it regularly possible to observe the presence of ITNs
in women’s sleeping quarters. Also, by relying on women’s
reported malaria treatment practices – because it was not
feasible to carry out direct observations of women’s drug
intake outside of the health facility – malaria self-
treatment and non-compliance with anti-malarial treat-
ment courses may have been underestimated across all
the sites. The lack of systematic observations of drug in-
take makes the cases of self-treatment and non-adherence
all the more striking and highlights a need for further
systematic analysis.
Conclusions
Respondents generally valued ITNs as malaria preven-
tion, however, availability and cost were barriers to ITNs
ownership. Sleeping arrangements, climatic conditions
and prioritizing infants led to inconsistent ITN use dur-
ing pregnancy. Health messages could address certain is-
sues, for example, if ITNs are left unused during
pregnancy so that they are new items to mark the birth
of a child.
In contrast, awareness of IPTp varied notably across
the sites and, together with past experience of side ef-
fects, low awareness contributed, to non-adherence. Al-
though IPTp was not always delivered under DOT,
adherence was common and this was linked to women’s
overall attempts to follow the instructions of health staff
and their positive evaluation of ANC as a package of
interventions.
Malaria diagnostic tests were not always available, but
confirming a malaria diagnosis through a blood test was
generally valued. However, there were examples of over-
treatment in Ghana and Malawi: in Ghana, this resulted
from misinterpretation of national policy, which illus-
trates the need for monitoring of local implementation.
Instance of self-treatment and non-compliance with pre-
scribed treatment courses were linked to the broad local
illnesses that overlapped with malaria, the cost and avail-
ability of anti-malarials at health facilities and individual
preferences – based on past and current experience of
the drugs. Health messages should therefore also address
adherence to prescribed anti-malarials as well as dis-
couraging self-treatment.
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